Delayed Graft Function: Clinical Trials

10 trials for Delayed Graft Function, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 2 recruiting, 1 terminated. 10 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 4, Unknown 3, Recruiting 2, Terminated 1
Phase 26Completed 3, Recruiting 2, Unknown 1

Follow Delayed Graft Function: new trials by email Literature Review of Delayed Graft Function trials Research Report on Delayed Graft Function

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients
Vonoprazan fumarate - Delayed Graft Function, Kidney Transplantation
Phase 1 / Phase 2RecruitingFirst Affiliated Hospital of Chongqing Medical University472025-12-102025-12-23
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
Treprostinil - Ischemia Reperfusion Injury, Delayed Graft Function
Phase 1 / Phase 2RecruitingRhode Island Hospital202020-11-132026-04-23
RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function
rhC1INH, Saline Solution - Kidney Failure
Phase 1UnknownUniversity of Wisconsin, Madison202019-06-212020-12-14
Renaparin® in Kidney Transplantation
Renaparin, Placebo - Delayed Graft Function
Phase 1CompletedCorline Biomedical AB162019-02-142020-07-01
Contrast-Enhanced Ultrasound for Kidney Transplant
Lumason Contrast-Enhanced Ultrasound - Kidney Transplantation
Phase 1TerminatedUniversity of Utah202018-02-212025-12-24
Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.
BM-MSCs, Saline - Kidney Transplantation, Acute Kidney Tubular Necrosis
Phase 1 / Phase 2UnknownFirst Affiliated Hospital, Sun Yat-Sen University1202015-11-012015-09-30
C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
C1 Esterase Inhibitor, Placebo - End Stage Renal Disease, Kidney Failure
Phase 1 / Phase 2CompletedCedars-Sinai Medical Center702014-09-012018-06-25
Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy
adipose derived stem cells - Delayed Graft Function
Phase 1UnknownMartha Haahr M.D302014-04-012015-10-16
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
I5NP, Saline - Delayed Graft Function, Other Complication of Kidney Transplant
Phase 1 / Phase 2CompletedQuark Pharmaceuticals3742008-12-012014-09-18
YSPSL for Prevention of Delayed Graft Function Part B
YSPSL, placebo - Kidney Diseases
Phase 1 / Phase 2CompletedY's Therapeutics, Inc.602006-05-012008-01-29

Narrower conditions

Renal Insufficiency (2)  ·  Reperfusion Injury (2)  ·  Acute Kidney Injury (1)  ·  Kidney Diseases (1)  ·  Kidney Failure, Chronic (1)  ·  Kidney Tubular Necrosis, Acute (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Pathologic Processes (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Male Urogenital Diseases (5)  ·  Urogenital Diseases (5)  ·  Urologic Diseases (5)  ·  Kidney Diseases (4)  ·  Cardiovascular Diseases (2)  ·  Postoperative Complications (2)  ·  Renal Insufficiency (2)  ·  Vascular Diseases (2)  ·  Acute Kidney Injury (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)

Interventions

Sodium Chloride (3)  ·  Saline Solution (2)  ·  Complement C1 Inhibitor Protein (1)  ·  conestat alfa (1)  ·  treprostinil (1)

Sponsors

Cedars-Sinai Medical Center (1)  ·  Corline Biomedical AB (1)  ·  First Affiliated Hospital of Chongqing Medical University (1)  ·  First Affiliated Hospital, Sun Yat-Sen University (1)  ·  Martha Haahr M.D (1)  ·  Quark Pharmaceuticals (1)  ·  Rhode Island Hospital (1)  ·  University of Utah (1)  ·  University of Wisconsin, Madison (1)  ·  Y's Therapeutics, Inc. (1)

Countries

United States (6)  ·  China (2)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Amir Sedigh, MD (1)  ·  Ashley Vo, PharmD (1)  ·  Changxi Wang, M.D., Ph.D (1)  ·  Isaac E Hall, M.D. (1)  ·  Luis Fernandez (1)  ·  Shai Erlich, Ph.D. (1)  ·  Stanley C Jordan, MD (1)  ·  Stefan Hemmerich, PhD (1)

Results publications

PMID 20573162, PMID 21114535, PMID 25974235, PMID 27077129

NIH funding

KL2TR002539 (1)